Manufacturer record
Dutch Formulations 32: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Dutch Formulations 32 (Himachal Pradesh) were declared Not of Standard Quality between October 2025 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: DL-1401, Ofloxacin IP, Ornidazole IP, Lopramide IP (exp Dec 2027). CFDL Jammu (state lab) found it not of standard quality: Description, Labelling, Assay and Misbranded. Listed in the September 2026 alert.
Records by type
4 records linked to Dutch Formulations 32 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ofloxacin IP, Ornidazole IP, Lopramide IP | Batch DL-1401Mfg Jan 2026 · Exp Dec 2027 | Description, Labelling, Assay and MisbrandedAssay | CFDL JammuState lab | Sep 2026 |
| Ofloxacin 100mg, Ornidazole 2500mg & Loperamide 7.5mg Bolus IP | Batch DF-1677Mfg Sep 2025 · Exp Aug 2027 | Assay of Ofloxacin, Ornidazole & LoperamideAssay | CFDL JammuState lab | Apr 2026 |
| Metformin Hydrochloride Tablets IP 1000 mg | Batch DL-60Mfg Oct 2024 · Exp Sep 2026 | The sample does not conform to claim as per IP 2022 and Addendum 2024 in respect to the Test Uniformity of weight and Assay of Metformin Hydrochloride.Assay | RDTL,ChandigarhCDSCO lab | Nov 2025 |
| Pantoprazole Gastro-resistant and Domperidone Tablets IP | Batch DL-57Mfg Oct 2024 · Exp Sep 2026 | The sample does not conform to claim as per Patent and Proprietary in respect to the Disintegration (Acid stage), Assay of Domperidone, Pantoprazole Sodium Calculated As Pantoprazole.Assay | RDTL, ChandigarhCDSCO lab | Oct 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.